David L. Eisenberg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
David L. Eisenberg has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
Gina M. Secura
From the Division of Clinical Research, Department of Obstetrics and Gynecology, Washington University in St Louis School of Medicine, St Louis, MO
2 shared publicationsJeffrey F. Peipert
2 shared publications- Jenifer E. Allsworth
Department of Biomedical and Health Informatics, School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA
2 shared publications - Mitchell D. Creinin
Department of Obstetrics and Gynecology, University of California, Davis; Sacramento, CA, United States
2 shared publications Qiuhong Zhao
2 shared publicationsAmi Desai
Northwestern University Feinberg School of Medicine
1 shared publication
Latest Publications
- Open Access
- 13 November 2026
- Published by Elsevier in Contraception
Minimally invasive management of placenta accreta spectrum at 21 weeks’ gestation: a case report
- 13 November 2026
- Published by Elsevier in Contraception
Open AccessMinimally invasive management of placenta accreta spectrum at 21 weeks’ gestation: a case report
- Open Access
- 2 November 2023
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 50, 101299
Low grade endometrial stromal sarcoma in pregnancy: A case in support of safe abortion access
- 2 November 2023
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 50, 101299
Open AccessLow grade endometrial stromal sarcoma in pregnancy: A case in support of safe abortion access
- 31 October 2023
- Published by Springer Nature in Abdominal Radiology
- Vol. 49 (1) , 237-248
CT imaging of intrauterine devices (IUD): expected findings, unexpected findings, and complications
Intrauterine devices (IUDs) are a commonly used form of long-acting reversible contraception, which either contain copper or levonorgestrel to prevent pregnancy. Although symptomatic patients with indwelling IUDs may first undergo ultrasound to assess for device malposition and complications, IUDs are commonly encountered on CT in patients undergoing evaluation for unrelated indications. Frequently, IUD malposition and complications may be asymptomatic or clinically unsuspected. For these reasons, it is important for the radiologist to carefully scrutinize the IUD on any study in which it is encountered. To do so, the radiologist must recognize that normally positioned IUDs are located centrally within the uterine cavity. IUDs are extremely effective in preventing pregnancy, though inadvertent pregnancy risk is higher with malpositioned IUDs. Presence of fibroids or Mullerian abnormalities may preclude proper IUD placement. Radiologists play an important role in identifying complications when they arise and special considerations when planning for an IUD placement. There is a wide range of IUD malposition, affecting IUDs differently depending on the type of IUD and its mechanism of action. IUD malposition is the most common complication, but embedment and/or partial perforation can and can lead to difficulty when removed. Retained IUD fragments can result in continued contraceptive effect. Perforated IUDs do not typically cause intraperitoneal imaging findings. Graphical abstract
- 31 October 2023
- Published by Springer Nature in Abdominal Radiology
- Vol. 49 (1) , 237-248
CT imaging of intrauterine devices (IUD): expected findings, unexpected findings, and complications
Intrauterine devices (IUDs) are a commonly used form of long-acting reversible contraception, which either contain copper or levonorgestrel to prevent pregnancy. Although symptomatic patients with indwelling IUDs may first undergo ultrasound to assess for device malposition and complications, IUDs are commonly encountered on CT in patients undergoing evaluation for unrelated indications. Frequently, IUD malposition and complications may be asymptomatic or clinically unsuspected. For these reasons, it is important for the radiologist to carefully scrutinize the IUD on any study in which it is encountered. To do so, the radiologist must recognize that normally positioned IUDs are located centrally within the uterine cavity. IUDs are extremely effective in preventing pregnancy, though inadvertent pregnancy risk is higher with malpositioned IUDs. Presence of fibroids or Mullerian abnormalities may preclude proper IUD placement. Radiologists play an important role in identifying complications when they arise and special considerations when planning for an IUD placement. There is a wide range of IUD malposition, affecting IUDs differently depending on the type of IUD and its mechanism of action. IUD malposition is the most common complication, but embedment and/or partial perforation can and can lead to difficulty when removed. Retained IUD fragments can result in continued contraceptive effect. Perforated IUDs do not typically cause intraperitoneal imaging findings. Graphical abstract
- 7 October 2020
- Published by Elsevier in Contraception
- Vol. 103 (1) , 26-31
Conception rates in women desiring pregnancy after levonorgestrel 52 mg intrauterine system (Liletta®) discontinuation
- 7 October 2020
- Published by Elsevier in Contraception
- Vol. 103 (1) , 26-31
Conception rates in women desiring pregnancy after levonorgestrel 52 mg intrauterine system (Liletta®) discontinuation
- 1 March 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (3) , 256.e1-256.e4
Threats to reproductive health care: time for obstetrician-gynecologists to get involved
- 1 March 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (3) , 256.e1-256.e4
Threats to reproductive health care: time for obstetrician-gynecologists to get involved
- 1 November 2016
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 215 (5) , 599.e1-599.e6
A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement
- 1 November 2016
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 215 (5) , 599.e1-599.e6
A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement
- Open Access
- 1 March 2013
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 68 (3) , 210-211
Continuation of the Etonogestrel Implant in Women Undergoing Immediate Postabortion Placement
Long-acting reversible contraceptive (LARC) methods can prevent repeat abortion. Two effective reversible LARC methods, the intrauterine device (IUD) and subdermal implant, have the potential to significantly reduce the rate of both unintended pregnancy and abortion. Some clinicians are concerned that women receiving an immediate postabortion etonogestrel implant may have higher rates of discontinuation compared with women who have the implant not in association with a recent pregnancy (interval insertion). Previous studies have not adequately investigated continuation rates for this implant following immediate postabortion insertion. The aim of this study was to compare 12-month continuation rates among women who received an immediate postabortion etonogestrel subdermal implant with those of women who had an interval insertion. The authors performed a secondary analysis of the Contraceptive CHOICE Project, a prospective cohort study designed to evaluate continuation and satisfaction for reversible LARC methods. Kaplan-Meier estimator of survival function and Cox proportional hazard models were used to compare continuation rates. Among 1178 women who received the implant during the study period, 141 received the implant immediately postabortion, and 935 had an interval insertion. Rates of 12-month continuation were similar in both groups: 81.5% for women who underwent immediate postabortion placement and 82.8% who had an interval placement (P = 0.54). Survival analysis showed that the likelihood of discontinuation among women who received an immediate postabortion implant was the same as those who had an interval placement; the adjusted hazard ratio was 1.04, with a 95% confidence interval of 0.68 to 1.60. In both groups, frequent or irregular bleeding was the most common reason given for discontinuation of the implant: 65.4% in the immediate postabortion group and 56.7% in the interval group (P = 0.29). These findings show that women who undergo immediate postabortion placement of the subdermal implant are no more likely to discontinue using it than women who have an interval placement. All women undergoing induced abortion should be offered immediate postabortion LARC to reduce the risk of unintended pregnancy and repeat abortion.
- 1 March 2013
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 68 (3) , 210-211
Open AccessContinuation of the Etonogestrel Implant in Women Undergoing Immediate Postabortion Placement
Long-acting reversible contraceptive (LARC) methods can prevent repeat abortion. Two effective reversible LARC methods, the intrauterine device (IUD) and subdermal implant, have the potential to significantly reduce the rate of both unintended pregnancy and abortion. Some clinicians are concerned that women receiving an immediate postabortion etonogestrel implant may have higher rates of discontinuation compared with women who have the implant not in association with a recent pregnancy (interval insertion). Previous studies have not adequately investigated continuation rates for this implant following immediate postabortion insertion. The aim of this study was to compare 12-month continuation rates among women who received an immediate postabortion etonogestrel subdermal implant with those of women who had an interval insertion. The authors performed a secondary analysis of the Contraceptive CHOICE Project, a prospective cohort study designed to evaluate continuation and satisfaction for reversible LARC methods. Kaplan-Meier estimator of survival function and Cox proportional hazard models were used to compare continuation rates. Among 1178 women who received the implant during the study period, 141 received the implant immediately postabortion, and 935 had an interval insertion. Rates of 12-month continuation were similar in both groups: 81.5% for women who underwent immediate postabortion placement and 82.8% who had an interval placement (P = 0.54). Survival analysis showed that the likelihood of discontinuation among women who received an immediate postabortion implant was the same as those who had an interval placement; the adjusted hazard ratio was 1.04, with a 95% confidence interval of 0.68 to 1.60. In both groups, frequent or irregular bleeding was the most common reason given for discontinuation of the implant: 65.4% in the immediate postabortion group and 56.7% in the interval group (P = 0.29). These findings show that women who undergo immediate postabortion placement of the subdermal implant are no more likely to discontinue using it than women who have an interval placement. All women undergoing induced abortion should be offered immediate postabortion LARC to reduce the risk of unintended pregnancy and repeat abortion.
- 1 June 2012
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 206 (6) , 479.e1-479.e9
Knowledge of contraceptive effectiveness
- 1 June 2012
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 206 (6) , 479.e1-479.e9
Knowledge of contraceptive effectiveness
- Open Access
- 1 January 2012
- Published by Wiley in Infectious Diseases in Obstetrics and Gynecology
- Vol. 2012, 1-6
Correlates of Dual-Method Contraceptive Use: An Analysis of the National Survey of Family Growth (2006–2008)
Objective. To analyze a nationally representative sample of women for correlates of dual-contraceptive-method use.Materials and Methods. We conducted an analysis of the National Survey of Family Growth, 2006–2008, a cross-sectional survey of reproductive-aged women in the United States.Results. Dual method use was reported by 7.3% of the 5,178 women in the sample. Correlates of higher rates of dual-contraceptive-method use included age younger than 36 years and nonmarried marital status. Lower rates of dual method use were observed for women with less than a high-school education and women without consistent health insurance in the past year. Compared to women using oral contraceptives, use of the contraceptive injection or long-acting reversible contraception was associated with lower dual-method use.Conclusions. The overall rate of dual-method use in the USA is low. Future interventions to promote dual method use should target high-risk groups with modifiable risk factors.
- 1 January 2012
- Published by Wiley in Infectious Diseases in Obstetrics and Gynecology
- Vol. 2012, 1-6
Open AccessCorrelates of Dual-Method Contraceptive Use: An Analysis of the National Survey of Family Growth (2006–2008)
Objective. To analyze a nationally representative sample of women for correlates of dual-contraceptive-method use.Materials and Methods. We conducted an analysis of the National Survey of Family Growth, 2006–2008, a cross-sectional survey of reproductive-aged women in the United States.Results. Dual method use was reported by 7.3% of the 5,178 women in the sample. Correlates of higher rates of dual-contraceptive-method use included age younger than 36 years and nonmarried marital status. Lower rates of dual method use were observed for women with less than a high-school education and women without consistent health insurance in the past year. Compared to women using oral contraceptives, use of the contraceptive injection or long-acting reversible contraception was associated with lower dual-method use.Conclusions. The overall rate of dual-method use in the USA is low. Future interventions to promote dual method use should target high-risk groups with modifiable risk factors.
- 1 August 2011
- Published by Elsevier in Contraception
- Vol. 84 (2) , 119-121
Controversies in family planning: timing of ovulation after abortion and the conundrum of postabortion intrauterine device insertion
- 1 August 2011
- Published by Elsevier in Contraception
- Vol. 84 (2) , 119-121
Controversies in family planning: timing of ovulation after abortion and the conundrum of postabortion intrauterine device insertion